A major pharma company had developed a treatment for a rare condition. However, two years after launch, the drug’s sales were far below expectations. Finding eligible patients for this new treatment was proving difficult because disease symptoms are heterogenous and patients can go years before being diagnosed correctly.
Learn how Datavant helped connect specialty drug data to real world data (RWD) in this case study.
Explore how Datavant can be your health data logistics partner.Contact us